|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
302168745 |
| 003 |
DE-627 |
| 005 |
20230905074132.0 |
| 007 |
tu |
| 008 |
990903s1998 cu ||||| 00| ||spa c |
| 020 |
|
|
|a 9592350132
|9 959-235-013-2
|
| 020 |
|
|
|z 9592350132
|
| 035 |
|
|
|a (DE-627)302168745
|
| 035 |
|
|
|a (DE-599)GBV302168745
|
| 035 |
|
|
|a (OCoLC)246990106
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a spa
|
| 044 |
|
|
|c XD-CU
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 084 |
|
|
|a 58.30
|2 bkl
|
| 100 |
1 |
|
|a Sasson, Albert
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Biotecnologías aplicadas a la producción de fármacos y vacunas
|c Albert Sasson
|
| 264 |
|
1 |
|a La Habana
|b Elfos Scientiae
|c 1998
|
| 300 |
|
|
|a 165 p
|b graph. Darst
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Literaturverz. S. 160 - 165
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4026655-2
|0 (DE-627)104483938
|0 (DE-576)208967443
|a Impfstoff
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4047347-8
|0 (DE-627)104270551
|0 (DE-576)209073292
|a Produktion
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/302168745.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 889 |
|
|
|w (DE-627)468610154
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_156
|
| 912 |
|
|
|a ISIL_DE-204
|
| 936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|0 (DE-627)106423304
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 936 |
b |
k |
|a 58.30
|j Biotechnologie
|0 (DE-627)106405365
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 35535912X
|c 00
|f SCHN
|d 2790-3614
|e --%%--
|j --%%--
|y k
|z 12-05-00
|
| 980 |
|
|
|2 156
|1 01
|x 0204
|b 67596301X
|c 00
|f FHMA
|d A 01 / 8988
|e u
|j --%%--
|c 05
|f --%%--
|d A 01::8988
|e --%%--
|j --%%--
|y z
|z 01-01-01
|
| 982 |
|
|
|2 156
|1 01
|x 0204
|8 00
|s s
|0 (DE-627)396747523
|a Biotechnologie
|
| 982 |
|
|
|2 156
|1 01
|x 0204
|8 01
|s s
|0 (DE-627)396814999
|a Pharmakologie
|
| 982 |
|
|
|2 156
|1 01
|x 0204
|8 02
|s s
|0 (DE-627)396785999
|a Impfungen
|
| 982 |
|
|
|2 156
|1 01
|x 0204
|8 03
|s g
|0 (DE-627)396721656
|a Cuba
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$027903614
|
| 984 |
|
|
|2 156
|1 01
|x 0204
|a 204006090048
|
| 985 |
|
|
|2 156
|1 01
|x 0204
|a A 01/08988
|
